TokenPost·
Scribe Therapeutics Posts $0.68 Q3 GAAP Loss Per Share, Beats Estimate
Revenue totaled $1.6 million, missing estimates by $2.12 million.
More news
- TokenPostCerebras Posts 55% Revenue Growth as Shares Rise After Hours
- TokenPostSouth Korea’s KOSPI Rises 2.05% as Chipmakers Gain More Than 3%
- Crypto BriefingUS Treasury plans Bitcoin custody framework as cold wallet security draws scrutiny
- TokenPostM&T Bank, Citizens, Travelers and Regions Post Q3 Results Oct. 16
- TokenPostKiro Adds Grok 4.7 to Four Paid Plans for AI-Assisted Coding
- TokenPostNvidia GPU Rental Rates Rise, With H200 Up Nearly 49% in a Month